Physician profile
Paul Yonover
NPI 1558356253
$179,281.82
in general payments reported to CMS, 2019-2025
59 companies · $96K in 2025
The $96K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $11K · 2021: $2,190 · 2022: $2,609 · 2023: $19K · 2024: $13K · 2025: $96K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $90K · Travel and Lodging: $20K · Food and Beverage: $9,618 · Honoraria: $7,100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $950 · Education: $19.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $90,285.50 |
| Travel and Lodging | $19,993.59 |
| Food and Beverage | $9,617.82 |
| Honoraria | $7,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $950.00 |
| Education | $19.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $96,123.27 | 2023-2025 | Illuccix |
| Astellas Pharma US INC | $24,147.93 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Accord Healthcare, INC. | $19,311.13 | 2022-2025 | |
| Pfizer INC. | $12,725.60 | 2019-2025 | |
| Augmenix, INC. | $6,023.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $3,067.05 | 2019-2025 | Adstiladrin |
| Clovis Oncology, INC. | $2,508.55 | 2019 | |
| Progenics Pharmaceuticals, INC. | $2,346.13 | 2021-2024 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $2,323.36 | 2019-2023 | |
| Janssen Scientific Affairs, LLC | $2,034.56 | 2022-2025 | |
| Blue Earth Diagnostics | $1,449.56 | 2021-2025 | Posluma |
| Janssen Biotech, INC. | $1,167.53 | 2019-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $825.38 | 2019-2025 | |
| Urogen Pharma, INC. | $775.58 | 2025 | |
| Medivators INC. | $500.00 | 2021 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $427.41 | 2019-2025 | Provenge |
| Boston Scientific Corporation | $385.72 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Axonics |
| Medtronic, INC. | $267.50 | 2022-2025 | Interstim, Altaviva |
| Olympus America INC. | $262.31 | 2021-2025 | Itind System, Hd Camera Head, Uretero-Reno Videoscope |
| Teleflex LLC | $229.45 | 2022-2025 | Barrigel |
| Sumitomo Pharma America, INC. | $223.16 | 2023-2025 | Gemtesa |
| Verity Pharmaceuticals INC. | $221.81 | 2022-2025 | Trelstar, Tlando |
| Merck Sharp & Dohme LLC | $218.49 | 2019-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Coloplast Corp | $185.75 | 2019-2025 | Speedicath |
| Novartis Pharmaceuticals Corporation | $178.65 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $164.98 | 2021-2024 | Lynparza |
| Tolmar Pharmaceuticals, INC. | $124.07 | 2019-2022 | |
| Procept Biorobotics Corporation | $91.20 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $83.58 | 2019-2023 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $72.18 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $68.17 | 2022 | |
| Allergan, INC. | $57.00 | 2020-2022 | |
| Tempus Ai, INC | $56.79 | 2024 | |
| 180 Medical, INC. | $49.71 | 2022-2024 | Gentlecath, Gentlecath Glide |
| Uroviu Corporation | $47.39 | 2022 | |
| Immunitybio, INC. | $47.09 | 2024-2025 | |
| Urovant Sciences INC | $44.99 | 2022 | |
| Myriad Genetic Laboratories, INC. | $40.54 | 2023-2024 | Prolaris, Myrisk |
| C. R. Bard, INC. & Subsidiaries | $38.66 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $27.25 | 2023 | Seglentis |
| Lantheus Medical Imaging, INC. | $26.69 | 2024 | |
| Palette Life Sciences, INC. | $25.65 | 2021 | |
| Smith+Nephew, INC. | $24.55 | 2019 | |
| Fennec Pharmaceuticals, INC. | $23.95 | 2025 | Fyarro |
| Terumo Medical Corporation | $22.89 | 2019 | |
| Amgen INC. | $21.15 | 2020 | |
| Endo USA, INC. | $21.08 | 2025 | Xiaflex |
| Calyxo, INC. | $21.05 | 2025 | Cvac Aspiration System |
| Tolmar, INC. | $21.01 | 2025 | Eligard, Jatenzo |
| Janssen Pharmaceuticals, INC | $20.19 | 2019 | |
| Cook Medical LLC | $18.27 | 2022 | |
| Civco Medical Instruments | $17.79 | 2025 | |
| Neotract INC. | $17.62 | 2019 | |
| Avyxa Pharma, LLC | $17.17 | 2025 | |
| Medtronic USA, INC. | $14.86 | 2020 | |
| Srs Medical Systems, INC. | $12.81 | 2023 | Urocuff |
| Metuchen Pharmaceuticals | $12.61 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$340,124.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Yonover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.